Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis.

Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis.
复制标题

过氧化物酶体增殖剂环丙贝特在两阶段肝癌发生中缺乏起始活性。

DOI:
10.1016/0304-3835(89)90003-7
复制
发表时间:
1989
期刊:
影响因子:
9.7
通讯作者:
Clark,TD
Clark,TD
中科院分区:
医学1区
文献类型:
--
作者:
Glauert,HP;Clark,TD

文献摘要

参考文献

被引文献

相似文献

The peroxisome proliferator ciprofibrate was examined for its ability to initiate hepatocarcinogenesis in rats. Ciprofibrate was fed in the diet at levels of 0%, 0.01% and 0.025% for 2 weeks in order to induce steady-state peroxisome proliferation. Rats were then subjected to partial hepatectomy and then maintained for 6 months on a basal diet or one containing 0.05% phenobarbital. Ciprofibrate treatment did not increase the number or volume of altered hepatic foci (putative preneoplastic lesions). However, ciprofibrate treatment increased liver weights in a dose-dependent manner in rats which did not receive phenobarbital.结论是环丙贝特诱导的过氧化物酶体增殖不足以诱导启动,但会产生永久性变化,导致肝脏重量增加。
The peroxisome proliferator ciprofibrate was examined for its ability to initiate hepatocarcinogenesis in rats. Ciprofibrate was fed in the diet at levels of 0%, 0.01% and 0.025% for 2 weeks in order to induce steady-state peroxisome proliferation. Rats were then subjected to partial hepatectomy and then maintained for 6 months on a basal diet or one containing 0.05% phenobarbital. Ciprofibrate treatment did not increase the number or volume of altered hepatic foci (putative preneoplastic lesions). However, ciprofibrate treatment increased liver weights in a dose-dependent manner in rats which did not receive phenobarbital. It is concluded that ciprofibrate-induced peroxisome proliferation is not sufficient to induce initiation, but that a permanent change is produced which results in an increased liver weight.
淋巴细胞[3H]胸苷和沙门氏菌诱变试验中降血脂过氧化物酶体增殖物的特性。
DOI: --
发表时间: 1980
期刊: Cancer Research
影响因子: 11.2
作者:
John R. Warren;Vincent F. Simmon;Janardan K. Reddy
通讯作者: Janardan K. Reddy
Wy-14,643(一种肝过氧化物酶体增殖剂)增强二乙基亚硝胺引发的大鼠肝肿瘤发生。
DOI: --
发表时间: 1978
影响因子: 8.8
作者:
J. Reddy;M. Rao
通讯作者: M. Rao
邻苯二甲酸二(2-乙基己酯):雌性 F-344 大鼠肝脏缺乏起始活性
DOI: 10.1093/carcin/8.2.285
发表时间: 1987
期刊: Carcinogenesis
影响因子: 4.7
作者:
L. K. Garvey;J. Swenberg;Thomas E. Hammn;J. Popp
通讯作者: J. Popp
邻苯二甲酸二(2-乙基己基)酯在大鼠肝癌发生中缺乏快速引发、促进或序贯致癌作用。
DOI: 10.1093/carcin/8.7.875
发表时间: 1987
期刊: Carcinogenesis
影响因子: 4.7
作者:
Williams,GM;Maruyama,H;Tanaka,T
通讯作者: Tanaka,T
DOI: 10.1038/271456a0
发表时间: 1978-01-01
期刊: NATURE
影响因子: 64.8
作者:
PITOT, HC;BARSNESS, L;KITAGAWA, T
通讯作者: KITAGAWA, T